3 March 2021 - 4 March 2021
Introduction to Health Technology Assessment
LEVEL - Introduction
TRACK - Health Technology Assessment
LENGTH: 4 Hour | 2 Consecutive Days; 2 Hours each Day
March 3, 2021 | 2 Hours
Course time in a variety of times zones:
08:00-10:00 Eastern Standard Time (EST)
13:00-15:00 Greenwich Mean Time (GMT)
14:00-16:00 Central European Time (CET)
March 4, 2021 | 2 Hours
Course time in a variety of time zones:
08:00-12:30 Eastern Standard Time (EST)
13:00-17:30 Greenwich Mean Time (GMT)
14:00-18:30 Central European Time (CET)
Basic Schedule:
Class Time: 2 hours on two consecutive days
Click for time zone conversion
DESCRIPTION
This course introduces the key elements, methods, and language of health technology assessment (HTA) and provides an overview of basic HTA principles including benefit assessment, economic evaluation, and ethical, legal, and social implications. Using real-world examples covering drugs, devices and public health measures, we review the practical steps involved in developing/using HTA reports.
This introductory course is designed to teach academic researchers, health policy decision makers, manufacturers, and clinicians about the key elements, methods, and language of health technology assessment (HTA). The course provides an overview of basic HTA principles including benefit assessment (biostatistics, clinical epidemiology, patient-relevant outcomes, risk-benefit assessment), economic evaluation (costing, cost-effectiveness analysis, pharmacoeconomic modeling, budget impact analysis, resource allocation), and ELSI (ethical, legal, and social implications). Using real world examples covering both drugs and devices, the course will review the practical steps involved in developing and using HTA reports in different countries and health care systems. Group discussion will focus on the perspectives of different stakeholders and the implementation of HTA in health care decision making. This course is suitable for those with little or no experience with HTA.
FACULTY MEMBERS
Uwe Siebert, MD, MPH, MSc, ScD
Professor & Chair
UMIT - University for Health Sciences, Medical Informatics and Technology
Innsbruck, Austria, and Harvard Chan School of Public Health, USA
Petra Schnell-Inderst, MPH, PhD, Dipl. Biol
Senior Scientist
UMIT - University for Health Sciences
Medical Informatics and Technology
Innsbruck, Austria